Kintara Therapeutics Inc. buy melinda
Start price
09.04.23
/
10%
€0.081
Target price
€0.15
Performance (%)
-
End price
02.05.23
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Kintara Therapeutics Inc. | - | - | - |
iShares Core DAX® | 2.594% | -1.158% | 14.782% |
iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% |
iShares Nikkei 225® | 0.687% | -8.354% | 18.454% |
iShares S&P 500 | 2.209% | -0.942% | 31.361% |
According to melinda what are the pros and cons of Kintara Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Delmar Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 0,15
In the thread Trading Delmar Pharmaceuticals Inc.
Buy beendet
Stopped prediction by melinda for Kintara Therapeutics Inc.
Kintara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.99
13.10.21
13.10.21
€1.50
13.10.22
13.10.22
-23.86%
24.10.21
24.10.21
Could be worthwhile Investment >10% per year
Kintara Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.21
29.09.20
29.09.20
€1.80
04.11.21
04.11.21
-18.78%
13.10.21
13.10.21
Could be worthwhile Investment >10% per year